Overhauling of Emergency Oxygen Bottle of Aircraft and Procurement of Life Items, Radar Kit Items, Armament Lifter, Digital X-Ray Machine, Biphasic Isophane Insulin, Omeprazole and Glimepride Tablets for Pakistan Air Force Base Nur Khan Rawalpindi

The Pakistan Air Force Base Nur Khan Rawalpindi is procuring a range of critical items including the overhauling of emergency oxygen bottles for aircraft, life-saving medical supplies, radar kit components, armament lifters, digital X-ray machines, and essential pharmaceuticals such as Biphasic Isophane Insulin, Omeprazole, and Glimepride tablets. This procurement is vital for maintaining operational readiness and medical support at the base. The technical scope covers the overhaul of oxygen bottles, procurement of life items for aircraft, radar kit items, armament lifters, and advanced medical equipment including digital X-ray machines. Additionally, pharmaceutical supplies like insulin and other medicines are included. The contract duration varies from 2 to 12 months after signing, depending on the item category. Eligible bidders should be registered with the Federal Board of Revenue (FBR) and possess relevant experience in supplying medical, aviation, and technical equipment. Firms must provide Earnest Money or CDR as per tender requirements and comply with all technical specifications outlined by the Pakistan Air Force. Submission of both technical and financial bids is mandatory. The tender was published on 23rd May 2026, with the closing date set firmly on 9th June 2026 at 1000 hours. Bidders must submit their documents to the Directorate of Procurement at PAF Base Nur Khan Rawalpindi before the deadline. Late submissions will not be entertained. A practical tip for bidders is to ensure all technical documentation and Earnest Money are complete and submitted well before the deadline to avoid disqualification. Attention to detail in the technical bid, especially regarding compliance with specifications for medical and aviation equipment, will enhance the chances of success.